Ovarian Cyst Pain: The Causes and Cure

                                                                                         

A lot of people are pretty down on the FDA these days, and rightly so: People are dying from, being harmed by, or becoming addicted to drugs the FDA approved. But they’re the only regulatory body we have and, while they need serious reform, it’s better than nothing.

For example, who would stop the nine different drug companies who manufacture and distribute dangerous addictive drugs, like certain varieties of morphine, without ever having gone through the FDA approval process?

There are some things that may be better left out of FDA hands – certain nutritional supplements, for example - but when it comes to morphine, that’s a different story. We’re not talking about a little pill of dried and concentrated spinach, morphine is a seriously dangerous addictive drug.

But why did the FDA delay so long on doing something about these illegally manufactured and distributed drugs? At least one of them, Roxicodone, has been around for years. The original manufacturer sold the rights to another company in 2003. Yet, here we are, nine years later, with the FDA just now cracking down on it.

The list of drugs being banned comprises 2% of the prescriptions filled annually in the U.S. That doesn’t sound like a lot, but when you consider there are billions of prescriptions written every year, you get an idea of how many drugs, and people, are involved.

Since the drugs being banned are highly addictive, it also raises the question of what will happen to those patients who have developed a prescription drug addiction when their drugs are off the market. The FDA statements about the ban make it clear that there are similar drugs available, which do have FDA approval. They might be more expensive, but they’re there. Like OxyContin.

In fact, that might answer the question of why the FDA delayed taking action for so long: the manufacturers who produce similar products, but with FDA approval, are getting litigious and lobbying to get rid of products that cut into their profits.

Maybe the FDA needs more reform than we thought.

About the author:
Gloria MacTaggart is a freelance writer that contributes articles on health.

info@drugrehabreferral.com

http://www.drugrehabreferral.com


Article Source: http://www.Free-Articles-Zone.com